CKD Clinical Trials

66 recruitingLast updated: June 18, 2026

There are 66 actively recruiting ckd clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Chicago, Illinois, United States, Birmingham, Alabama, United States, Ankara, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


CKD Trials at a Glance

66 actively recruiting trials for ckd are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in Chicago, Birmingham, and Ankara. Lead sponsors running ckd studies include National Taiwan University Hospital, Hacettepe University, and Grigore T. Popa University of Medicine and Pharmacy.

Browse ckd trials by phase

Treatments under study

About CKD Clinical Trials

Looking for clinical trials for CKD? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CKD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CKD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 66 trials

Recruiting
Phase 1

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

Kidney Disease, ChronicChronic Kidney DiseaseKidney Disease+2 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07572890
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University750 enrolled7 locationsNCT06906627
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University420 enrolled7 locationsNCT06906640
Recruiting

Precision Medicine Approaches to Renal Osteodystrophy

Chronic Kidney DiseasesCkd-MbdSecondary Hyperparathyroidism+2 more
Thomas Nickolas40 enrolled1 locationNCT05880914
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

CKDMetabolic Acidosis
Renibus Therapeutics, Inc.150 enrolled19 locationsNCT07355062
Recruiting
Phase 2

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

Heart FailureCardiovascular DiseasesCKD
University Medical Center Groningen100 enrolled2 locationsNCT07304817
Recruiting

Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca1,282 enrolled29 locationsNCT06744335
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

Acute Kidney InjuryChronic Kidney Disease(CKD)Cystic Fibrosis (CF)
University of Virginia260 enrolled3 locationsNCT06595420
Recruiting
Phase 1Phase 2

A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals20 enrolled9 locationsNCT05106387
Recruiting
Not Applicable

Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength

Chronic Kidney Disease(CKD)
VA Office of Research and Development250 enrolled2 locationsNCT06607913
Recruiting
Not Applicable

Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)CKD Stage 1-3
Fu Jen Catholic University Hospital60 enrolled1 locationNCT07493642
Recruiting
Phase 1

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics15 enrolled1 locationNCT07275788
Recruiting
Not Applicable

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

CKDMalnutrition (Calorie)Low Protein Dietary Intake
Fresenius Kabi Taiwan Ltd.80 enrolled3 locationsNCT06892249
Recruiting
Phase 2

Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis

CKD (Chronic Kidney Disease) Stage 5DESRD
McGill University Health Centre/Research Institute of the McGill University Health Centre30 enrolled1 locationNCT06913647
Recruiting
Not Applicable

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

Chronic Kidney Disease(CKD)
University of Illinois at Chicago40 enrolled1 locationNCT06754280
Recruiting

Multifrequency MRE in Evaluation of Chronic Kidney Diseases

Chronic Kidney Disease(CKD)
Shengjing Hospital200 enrolled1 locationNCT06202235
Recruiting
Not Applicable

The Effects of Dietary Nitrate in Patients With Hypertensive Kidney Injury

HypertensionCKD - Chronic Kidney Disease
Gødstrup Hospital20 enrolled1 locationNCT07290842
Recruiting

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

CKDRenal Insufficiency, ChronicCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder+1 more
University of Copenhagen50 enrolled2 locationsNCT07312981